| scholarly article | Q13442814 |
| P2093 | author name string | Sai Wah Tsao | |
| Chi Man Tsang | |||
| Shaina Chor Mei Huang | |||
| P2860 | cites work | Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI | Q24312126 |
| An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 | ||
| Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed | Q25257225 | ||
| Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer | Q26798047 | ||
| Novel mechanisms of EBV-induced oncogenesis | Q27006524 | ||
| Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence | Q27007474 | ||
| Discovery of IL-8/CXCL8 (The Story from Frederick) | Q28088731 | ||
| Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma | Q28200526 | ||
| Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance | Q28275420 | ||
| The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity | Q28281686 | ||
| Regulation of cancer cell metabolism | Q28303890 | ||
| The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma | Q28540190 | ||
| Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. | Q51995543 | ||
| LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1 | Q57198201 | ||
| Epidemiology of nasopharyngeal carcinoma in Malaysia and Hong Kong | Q69794060 | ||
| Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells | Q77304089 | ||
| Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type | Q78819602 | ||
| The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors | Q80284096 | ||
| Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival | Q84075126 | ||
| Nasopharyngeal carcinoma | Q86035551 | ||
| Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma. | Q40055132 | ||
| Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma | Q40078689 | ||
| Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40. | Q40089018 | ||
| LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. | Q40113219 | ||
| Release of inflammatory mediators from stimulated neutrophils. | Q40120046 | ||
| Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages. | Q40209668 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma. | Q40449755 | ||
| Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. | Q40457809 | ||
| Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration | Q40547314 | ||
| Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells | Q40577418 | ||
| Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells. | Q40762518 | ||
| Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma | Q40860124 | ||
| Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. | Q40870284 | ||
| The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. | Q41371042 | ||
| Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor | Q41593065 | ||
| Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation | Q41736955 | ||
| Etiological factors of nasopharyngeal carcinoma | Q42231417 | ||
| Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. | Q42435176 | ||
| CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. | Q42527769 | ||
| Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma | Q45353248 | ||
| Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma | Q45406960 | ||
| Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma | Q45640598 | ||
| Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. | Q45656306 | ||
| Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. | Q45735984 | ||
| Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation | Q45751104 | ||
| Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. | Q45756231 | ||
| Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma | Q45761361 | ||
| Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma | Q45841235 | ||
| RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target? | Q47106594 | ||
| Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma | Q47248660 | ||
| EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma | Q47259217 | ||
| Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 | Q33265945 | ||
| Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy | Q33305203 | ||
| A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages | Q33335343 | ||
| Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma | Q33598586 | ||
| Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing | Q33700293 | ||
| Dissecting the regulation of EBV's BART miRNAs in carcinomas | Q33892295 | ||
| VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 | ||
| MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1 | Q34059350 | ||
| Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes | Q34171808 | ||
| Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy | Q34171822 | ||
| Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis | Q34228703 | ||
| Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction | Q34261571 | ||
| Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease | Q34278487 | ||
| Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. | Q34282719 | ||
| Ectopic expression of DICE1 suppresses tumor cell growth. | Q34333513 | ||
| Cytokine patterns in patients with cancer: a systematic review. | Q34342581 | ||
| Human tumor virus utilizes exosomes for intercellular communication. | Q34377767 | ||
| Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells | Q34382544 | ||
| Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells | Q34507851 | ||
| Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations | Q34549536 | ||
| Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack | Q34592338 | ||
| LMP1 strain variants: biological and molecular properties. | Q34717145 | ||
| Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma | Q34745799 | ||
| The biological role of the Fas/FasL system during tumor formation and progression | Q34766094 | ||
| The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis | Q34812044 | ||
| The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
| Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 | ||
| The significance of LMP1 expression in nasopharyngeal carcinoma | Q35008886 | ||
| EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy | Q35067875 | ||
| Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes | Q35077651 | ||
| Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling | Q35194008 | ||
| Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma. | Q35570420 | ||
| EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival | Q35662292 | ||
| Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration | Q35755712 | ||
| Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma | Q35781438 | ||
| Epstein-Barr virus: more than 50 years old and still providing surprises. | Q38968588 | ||
| Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells | Q39016871 | ||
| NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma. | Q39105321 | ||
| Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma | Q39306381 | ||
| Epstein-Barr viral microRNAs target caspase 3. | Q39449661 | ||
| Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells | Q39578660 | ||
| MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. | Q39664249 | ||
| Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines | Q39679329 | ||
| Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition | Q39682274 | ||
| The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. | Q39806231 | ||
| Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. | Q39903979 | ||
| Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro | Q39927855 | ||
| Efficiency of transformation of lymphocytes by Epstein-Barr virus | Q40044594 | ||
| Epstein-Barr virus infection and nasopharyngeal carcinoma | Q40046633 | ||
| Epithelial-mesenchymal transitions: twist in development and metastasis | Q35856121 | ||
| Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma | Q35865016 | ||
| The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. | Q35924384 | ||
| Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9 | Q36086653 | ||
| Modulation of LMP1 protein expression by EBV-encoded microRNAs | Q36092565 | ||
| Epstein-Barr virus: an important vaccine target for cancer prevention | Q36408680 | ||
| EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma | Q36414449 | ||
| Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis | Q36467398 | ||
| Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. | Q36486650 | ||
| Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells | Q36498181 | ||
| EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC | Q36561585 | ||
| Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. | Q36697762 | ||
| Alterations of the p53 gene in nasopharyngeal carcinoma | Q36698270 | ||
| Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells | Q36734903 | ||
| Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells | Q36753036 | ||
| Potential selection of LMP1 variants in nasopharyngeal carcinoma | Q36944141 | ||
| Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma | Q37022210 | ||
| The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications | Q37160617 | ||
| E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer | Q37372547 | ||
| Clonal transformation of adult human leukocytes by Epstein-Barr virus | Q37506764 | ||
| Role of EBNA1 in NPC tumourigenesis | Q37972201 | ||
| Host-tumor interactions in nasopharyngeal carcinomas | Q37976234 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 | ||
| Switching of EBV cycles between latent and lytic states | Q38171455 | ||
| The role of Epstein-Barr virus in epithelial malignancies | Q38253914 | ||
| The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma | Q38440804 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3. | Q38714699 | ||
| Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways | Q38722933 | ||
| Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin | Q38826798 | ||
| Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins. | Q38889253 | ||
| Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells | Q38928572 | ||
| Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells | Q38943928 | ||
| EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. | Q38944897 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P577 | publication date | 2018-04-04 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma. | |
| P478 | volume | 10 |
| Q92630095 | Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways |
| Q90134450 | HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma |
| Q91799878 | Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells |
| Q92460554 | LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma |
| Q57287797 | Low PD-L1 Expression Strongly Correlates with Local Recurrence in Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma after Radiation-Based Therapy |
| Q90012585 | Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression |
| Q94526791 | Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma |
| Q92276560 | Strand-specific miR-28-3p and miR-28-5p have differential effects on nasopharyngeal cancer cells proliferation, apoptosis, migration and invasion |
| Q57120826 | The Predictive Value of Epstein-Barr Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant Chemotherapy |
| Q64946489 | The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. |
Search more.